New York Ventures

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the Regional Economic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

Audrey Chisholm

Investment Associate

Silvia Garcia Codony

Assistant Vice President

Heidi Knoblauch

Senior Director

Josh Nelson

Director

Ryoko Nozawa

Senior Director

56 past transactions

Toggle

Series A in 2023
Toggle they develop robotics and automation solutions and providing pre-assembly services.

SimpliFed

Seed Round in 2022
SimpliFed is a telehealth company that provides access to virtual breastfeeding support to new and pregnant parents. It was founded in 2020 catering to new parents, who struggle with sleep deprivation, uncertainty, and complex questions about their infant’s nutrition.

Ecolectro

Seed Round in 2022
Ecolectro is bringing scalable, low-cost, clean green hydrogen energy to the very near future. Our electrolyzers integrate patented polymers into durable, high performance stacks. Our scientists and engineers design and build units with our exceptional membranes and electrodes, delivering high production rates and efficiency of pure hydrogen without the need for platinum, iridium and titanium. We continue to push the limits of electrolysis technology with an emphasis on research and willingness to challenge assumptions.

Whose Your Landlord

Seed Round in 2022
Whose Your Landlord is a multipurpose platform that empowers and informs the rental community. We use the information provided by our renters to extend feedback to landlords, improve the tenants' experience, and reduce turnover. On WYL renters post landlord reviews, receive community-centered insights, and are given access to quality listings.

OWL Autonomous Imaging

Series A in 2022
Owl Autonomous Imaging delivers Monocular 3D Thermal Ranging™ solutions to industrial and automotive mobility markets to dramatically enhance safety day or night and in all weather conditions. Thermal Ranging™ is a new 3D modality that uses optical fusion and novel deep learning techniques to extract dense range maps from radiated heat signatures, without requiring illumination. Owl was co-founded by Chuck Gershman. Mr. Gershman has 30 years of semiconductor industry experience in executive management, marketing, engineering, business development, sales, consulting and executive advising. A serial entrepreneur, Mr. Gershman has been a member of the executive team of five startups, three of which as CEO/COO. He has had successful exits with acquisitions by Intel and PMC-Sierra. Further company information can be found at www.owlai.us

Yuvo Health

Seed Round in 2022
Yuvo provides health centers with the resources they need. The company provides administrative and managed-care contracting services to federally qualified health centers (FQHCs) empowering them to unlock revenue streams through value-based care, enabling health centers and their patients to enjoy the benefits without assuming risk, burning out staff, or drowning in data.

BlocPower

Venture Round in 2022
BlocPower is an energy technology startup based in Los Angeles, California, focused on developing sustainable solutions for buildings. The company provides solar power and energy efficiency products aimed at reducing energy costs for churches, schools, small businesses, non-profits, and homeowners. By leveraging data, thermodynamic models, and advanced technology, BlocPower upgrades buildings to make them healthier, greener, and smarter, while also tackling carbon emissions. The company collaborates with various stakeholders, including governments, utilities, building owners, lenders, contractors, and equipment providers, to electrify buildings and promote energy savings, particularly in financially underserved communities. Through its initiatives, BlocPower aims to contribute to the creation of environmentally friendly and healthy urban spaces.

OncoPrecision

Seed Round in 2021
Leveraging single cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.

Envisagenics

Series A in 2021
Envisagenics focus on the discovery of RNA therapeutics. Their mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Their breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug targets, and develop RNA therapeutics through partnerships and collaborations with Biopharma. Their in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs. Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory.

REDIST

Seed Round in 2021
A platform making it easy for real estate professionals to find and use the more than $100b in annual real estate incentives; saving time and money on deals. Our current geographic coverage is New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, Florida, Washington D.C. and Virginia. We are located at the Columbia Startup Lab, are currently in Lowenstein Sandler's VentureCrush FG as well as Shadow Ventures Incubator and have recently completed Accelerate 2020 with Bowery Capital and Silicon Valley Bank.

Toggle

Series A in 2021
Toggle they develop robotics and automation solutions and providing pre-assembly services.

Dimensional Energy

Seed Round in 2021
Dimensional Energy is a chemistry company pioneering artificial photosynthesis to produce environmentally responsible polymers and chemical intermediaries. Dimensional Energy is making solar fuels viable through efficient utilization and even distribution of sunlight in scalable reactor forms with novel, functionalized catalysts.

OWL Autonomous Imaging

Seed Round in 2021
Owl Autonomous Imaging delivers Monocular 3D Thermal Ranging™ solutions to industrial and automotive mobility markets to dramatically enhance safety day or night and in all weather conditions. Thermal Ranging™ is a new 3D modality that uses optical fusion and novel deep learning techniques to extract dense range maps from radiated heat signatures, without requiring illumination. Owl was co-founded by Chuck Gershman. Mr. Gershman has 30 years of semiconductor industry experience in executive management, marketing, engineering, business development, sales, consulting and executive advising. A serial entrepreneur, Mr. Gershman has been a member of the executive team of five startups, three of which as CEO/COO. He has had successful exits with acquisitions by Intel and PMC-Sierra. Further company information can be found at www.owlai.us

Ursa Space Systems

Series B in 2021
Ursa Space Systems is a space 3.0 analytics-as-a-service company that brings transparency to global markets to help traders and analysts in the finance and energy industries make more informed decisions. It uses space-based data from radar satellites as the source of its timely reports.

Yuvo Health

Pre Seed Round in 2021
Yuvo provides health centers with the resources they need. The company provides administrative and managed-care contracting services to federally qualified health centers (FQHCs) empowering them to unlock revenue streams through value-based care, enabling health centers and their patients to enjoy the benefits without assuming risk, burning out staff, or drowning in data.
Energy Materials Corporation develops high-speed, roll-to-roll printing of purebred perovskite solar panels. The company was founded in 2010 and based in Rochester, New York.

Shur

Pre Seed Round in 2021
Shur is a B2B2C connecting the financial services industry to millions of Professionals with Student Loans. Our company-based financial wellness programs integrate alternative credit scoring, advice, insurance, and banking. Borrowers move from debt to wealth creation, while we build new revenue for banks and other financial institutions.

BlocPower

Series A in 2021
BlocPower is an energy technology startup based in Los Angeles, California, focused on developing sustainable solutions for buildings. The company provides solar power and energy efficiency products aimed at reducing energy costs for churches, schools, small businesses, non-profits, and homeowners. By leveraging data, thermodynamic models, and advanced technology, BlocPower upgrades buildings to make them healthier, greener, and smarter, while also tackling carbon emissions. The company collaborates with various stakeholders, including governments, utilities, building owners, lenders, contractors, and equipment providers, to electrify buildings and promote energy savings, particularly in financially underserved communities. Through its initiatives, BlocPower aims to contribute to the creation of environmentally friendly and healthy urban spaces.

Mymee

Venture Round in 2021
Mymee is a remote care and support services company for people struggling with incurable rheumatic and neurological autoimmune diseases. Mymee programs combine expert health coaching, trigger identification and personalized care plans to reduce disease flares based on each individual's unique diet, lifestyle and environmental triggers. Results with Mymee in a randomly controlled trial demonstrated clinically significant improvements in 9 out of 10 health-related quality of life domains, including fatigue and pain among others.

Conamix

Venture Round in 2020
Conamix is commercializing new low-cost high-energy materials for the global lithium-ion battery market. The company’s materials are designed to drop-in to existing manufacturing infrastructure to both improve the energy density and lower the cost of lithium-ion systems. Founded in 2014, the company is led by an experienced team of chemical and battery industry leaders and has intellectual property agreements with multiple leading global research institutions.

TARA Biosystems

Series A in 2020
Tara Biosystems provides predictive, in vitro human cardiac tissue models for use in drug discovery, safety assessment and translational medicine. Tara Biosystems offers a high-fidelity solution that is based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The company is dedicated to pioneering predictive cardiac tissue models that enable the faster, safer, and more reliable development of new medicines.

Vyv

Series A in 2020
Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well as a licensing model for consumer and residential products.

MyndYou

Series A in 2020
The MyndYou artificial intelligence (AI) based platform aids clinicians in providing personalized cognitive care for seniors living with or without cognitive decline. The MyndYou solution combines one-on-one remote interaction with a seamless monitoring app, analytic evaluation, and AI analysis to individualize care based on passively collected data from the client’s daily activities. The platform delivers actionable, objective insights in real-time to therapists during remote calls, guiding the nature and level of cognitive training. As cognitive related disease such as dementia and Alzheimer’s continues to grow at a rapid pace, MyndYou optimizes and scales the targeted delivery of cognitive care.

Redpin Therapeutics

Series A in 2020
Redpin Therapeutics operates as a preclinical stage gene therapy company. It develops a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Its approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. The company was founded in 2017 and is headquartered in New York.

Ride Health

Series A in 2020
Ride Health partners with healthcare organizations and transportation providers to manage transportation benefits, strengthen enterprise transportation programs, and improve access to care and social services for at-risk populations. We blend technology and data with a human approach to break down access barriers and solve some of the biggest transportation challenges that payers, providers, and life science organizations face. Our platform maps out each patient’s unique needs and preferences for the best ride experience across clinical and social needs, ensuring greater access, improved efficiencies, lower costs, and better outcomes.

Soundmind

Seed Round in 2019
Soundmind is a developer of a conversational voice assistant made to keep people linked and lessen social isolation. The voice assistant provided by their business enables administrators and guardians to manage elder residents' accounts and deliver personalized calendar information, reminders, messaging, and entertainment via voice, enhancing communication for older adults and their families throughout the continuum of care.

Token

Series A in 2019
We have developed the next generation of MFA that stops phishing and unauthorized logins for organizations where ransomware must be stopped

Ursa Space Systems

Series B in 2019
Ursa Space Systems is a space 3.0 analytics-as-a-service company that brings transparency to global markets to help traders and analysts in the finance and energy industries make more informed decisions. It uses space-based data from radar satellites as the source of its timely reports.

Kangarootime

Series A in 2019
Kangarootime helps childcare professionals with a cloud-based mobile application that collects payments, automates 'check-in' and 'check-out,' and streamlines communication and compliance. Every care center can create a better connection with the families that they serve. Kangarootime.com automates check-in and child-specific instructions for daily care.

SomaDetect

Seed Round in 2019
SomaDetect is the world’s premier machine learning and artificial intelligence company in dairy. SomaDetect provides real-time, automated analysis of milk quality without any addition of chemicals or consumables. The company measures every compound of interest in raw milk, enabling farmers to identify issues early, manage reproduction, reduce unnecessary antibiotic usage, and ensure that only the highest-quality milk makes it into bulk milk supplies. Founded in 2016, SomaDetect provides dairy farmers with information about herd health and milk quality, where and when they need it most.

Concertio

Seed Round in 2019
Concertio is a premier provider of AI-powered performance optimization tools for the hardware and software markets. It also provides AI-powered performance optimization tools that boost the performance of computing systems by tailoring the many system settings in processors, firmware, OS and applications to the running workloads. The company tools are used by the likes of Intel, Marvell, and Mellanox to boost the performance of a multitude of devices and applications, turning general-purpose systems into high-performant special-purpose systems. The optimizer studio integrates performance optimization software suite that monitors (and learns from) the interactions between applications and systems, to deliver optimal configuration settings for peak performance. Concertio was founded in 2016 and is headquartered in New York, NY, USA.

Artemis

Series A in 2019
Artemis operates an intelligence platform for indoor farms. It specializes in indoor farming software solutions. Artemis help indoor farm operators use data to make more profitable production decisions. It tracks and analyzes all farm data in one place, enabling growers to optimize plant performance and reduce operating expenses. Allison Kopf and Jason Camp founded Agrilyst in 2015 that later became Artemis. It has its headquarters in Brooklyn in New York City.

Unite Us

Series B in 2019
Unite Us is a veteran-led technology company that builds coordinated care networks connecting health and social service providers together. The company helps systems and communities efficiently deliver care and services by inter-connecting providers across communities, seamlessly integrating the social determinants of health into patient care. Providers across the continuum and community are able to externally refer and track every patient’s total health journey while reporting on all tangible outcomes across a full range of services in a centralized, cohesive, and collaborative ecosystem. This social infrastructure helps communities move beyond legacy resource directories, and transform their ability to measure impact, improved health, and outcomes at scale. The company was founded in 2013 by military veterans Dan Brillman and Taylor Justice in New York, New York.

LOLIWARE

Seed Round in 2019
LOLIWARE’s mission is to advance the planet towards a plastic-free, decarbonized future with products that are Designed to Disappear. We’re an award-winning materials tech company and we are replacing single-use plastics with bio-renewable seaweed-derived alternatives. The team bringing this vision to life is a diverse and global group of planetary visionaries, scientists, engineers, business leaders, strategists, and technologists with a shared vision for a plastic-free future. And additionally, we’ve formed a very high caliber scientific advisory board with Dr. Carlos Duarte, a world-renowned marine scientist guiding our seaweed supply chain, Dr. Louis Metzger formerly chief scientific officer at Tierra Biosciences, and Dr. Garret Miyake, an award-winning chemist, Sloan research fellow, and co-founder of Cypris materials. There’s an increasing number of biobased alternatives on the market, but not all products are created equal. There are concerns about their true environmental impact as compared to plastic. Biodegradability is one critical factor to consider, but we must also look at the carbon footprint. Some current options such as paper straws carry a carbon footprint of 2-3X more than plastic itself while others have made false claims around their biodegradability. A better future necessitates an alternative that is proven to be compostable, carbon negative, and scalable. LOLIWARE was just awarded top product of the year from Environmental + Energy leader because they believe we have the ability to set a new industry standard for single-use plastics Our first product is a home compostable, ocean safe, tree-free, drinking straw. But it’s important to note that LOLIWARE is not a straw company, we are a biopolymer company with applications in every category of single-use plastics. LOLIWARE is focused on 6 new products by the close of 2023.

Kinvolved

Seed Round in 2018
Kinvolved is a developer of a social enterprise platform designed to improve student attendance and reduce chronic absenteeism. The company's platform combines web, mobile and tablet technology tools with expert consulting and community engagement events, enabling schools to increase funding, create more economically viable communities and improve graduation rates.

MouSensor

Seed Round in 2018
MouSensor is an early-stage biotech company.

ENB Therapeutics

Series A in 2018
ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients. Its lead product, ENB-001, is a first-in-class, selective small molecule endothelin B receptor (ETBR) inhibitor shown in multiple preclinical studies to significantly reduce tumor growth and prolong survival in cancer animal models. ENB-001 is the key to unlock the full therapeutic potential of immunotherapy by restoring the ability of T-cells to infiltrate tumors, inhibiting metastasis, and prolonging patient survival. Granted Orphan Drug Designation by FDA in 2016, ENB-001 has solid market exclusivity and strong IP. A low cost, time-efficient development program provides near-term POC within 18 months from financing. A companion diagnostic will detect ETBR pathway over-expressers creating additional opportunities for indication expansion into multiple tumor types and broader participation in the multi-billion-dollar immunotherapy market. Its products, as combination therapy with immuno-oncology agents, create a new and superior standard of care that blocks key mechanisms of drug resistance, stimulates the immune system to fight cancer, and prevents cancer from spreading. ENB Therapeutics was founded in 2015 and is headquartered in New York, New York.

PostProcess Technologies

Series A in 2018
PostProcess Technologies is a provider of automated and intelligent post-printing solutions for additive manufacturing. The company's comprehensive system of proprietary software, patent-pending hardware, and additive-formulated chemistry works together to remove the bottleneck in the third step of additive manufacturing — post-printing.

GiveGab

Series A in 2018
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.

Artemis

Venture Round in 2018
Artemis operates an intelligence platform for indoor farms. It specializes in indoor farming software solutions. Artemis help indoor farm operators use data to make more profitable production decisions. It tracks and analyzes all farm data in one place, enabling growers to optimize plant performance and reduce operating expenses. Allison Kopf and Jason Camp founded Agrilyst in 2015 that later became Artemis. It has its headquarters in Brooklyn in New York City.

Conamix

Series A in 2018
Conamix is commercializing new low-cost high-energy materials for the global lithium-ion battery market. The company’s materials are designed to drop-in to existing manufacturing infrastructure to both improve the energy density and lower the cost of lithium-ion systems. Founded in 2014, the company is led by an experienced team of chemical and battery industry leaders and has intellectual property agreements with multiple leading global research institutions.

Cureatr

Venture Round in 2018
Cureatr develops a cloud-based medication management software to optimize patient care. It offers healthcare management services that focus on post-discharge medication reconciliation and other medical services triggered by real-time events.

GiveGab

Series A in 2018
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.

Redpin Therapeutics

Venture Round in 2018
Redpin Therapeutics operates as a preclinical stage gene therapy company. It develops a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Its approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. The company was founded in 2017 and is headquartered in New York.

Citymart

Seed Round in 2018
Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.

Token

Series A in 2018
We have developed the next generation of MFA that stops phishing and unauthorized logins for organizations where ransomware must be stopped

Quentis Therapeutics

Series A in 2018
Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to target ER stress pathways and awaken the immune system's ability to fight cancer, enabling patients to get access to new treatments for cancer.

Vyv

Venture Round in 2018
Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well as a licensing model for consumer and residential products.

TARA Biosystems

Series A in 2017
Tara Biosystems provides predictive, in vitro human cardiac tissue models for use in drug discovery, safety assessment and translational medicine. Tara Biosystems offers a high-fidelity solution that is based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The company is dedicated to pioneering predictive cardiac tissue models that enable the faster, safer, and more reliable development of new medicines.

Unite Us

Series A in 2017
Unite Us is a veteran-led technology company that builds coordinated care networks connecting health and social service providers together. The company helps systems and communities efficiently deliver care and services by inter-connecting providers across communities, seamlessly integrating the social determinants of health into patient care. Providers across the continuum and community are able to externally refer and track every patient’s total health journey while reporting on all tangible outcomes across a full range of services in a centralized, cohesive, and collaborative ecosystem. This social infrastructure helps communities move beyond legacy resource directories, and transform their ability to measure impact, improved health, and outcomes at scale. The company was founded in 2013 by military veterans Dan Brillman and Taylor Justice in New York, New York.

PostProcess Technologies

Seed Round in 2017
PostProcess Technologies is a provider of automated and intelligent post-printing solutions for additive manufacturing. The company's comprehensive system of proprietary software, patent-pending hardware, and additive-formulated chemistry works together to remove the bottleneck in the third step of additive manufacturing — post-printing.

SeamlessDocs

Series B in 2016
The leading provider of online government services, SeamlessDocs is the fastest and easiest way for governments to go digital. The SeamlessDocs platform allows agencies to create online forms, accept eSignatures, process payments, trigger workflows and manage submission data, enabling IT and administration to make their government processes beautiful. Founded in 2012, SeamlessDocs works with more than 400 municipal departments across the United States, as well as Canada and The Caribbean.

ChannelEyes

Venture Round in 2016
Founded in 2011, ChannelEyes is a global software company that is reinventing how vendors drive channel partner sales and loyalty. The SaaS platform includes ChannelCandy, the world’s largest mobile-first product for partners, as well as OPTYX, the first indirect sales workflow product to help sellers with predictive analytics and leverage big data science to drive more sales. ChannelEyes has received numerous accolades for its technology including being named a Cool Vendor by Gartner and one of the fastest growing companies in New York’s Capital Region by the Business Review. Learn more at: http://channeleyes.com/

Unite Us

Series A in 2015
Unite Us is a veteran-led technology company that builds coordinated care networks connecting health and social service providers together. The company helps systems and communities efficiently deliver care and services by inter-connecting providers across communities, seamlessly integrating the social determinants of health into patient care. Providers across the continuum and community are able to externally refer and track every patient’s total health journey while reporting on all tangible outcomes across a full range of services in a centralized, cohesive, and collaborative ecosystem. This social infrastructure helps communities move beyond legacy resource directories, and transform their ability to measure impact, improved health, and outcomes at scale. The company was founded in 2013 by military veterans Dan Brillman and Taylor Justice in New York, New York.

Cureatr

Series B in 2015
Cureatr develops a cloud-based medication management software to optimize patient care. It offers healthcare management services that focus on post-discharge medication reconciliation and other medical services triggered by real-time events.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.